The project aims to discover new chemical compounds that can reverse the toxicity of TDP-43. A miniaturized assay was developed to screen the MLSMR for TDP-43 inhibitors, and compounds that inhibit TDP-43 are labeled as activators. Is the molecule effective to this assay?